Kenneth Stein, MD, FACC, FHRS, is currently Senior Vice President and Chief Medical Officer for Rhythm Management and Global Health Policy at Boston Scientific. Ken is a Phi Beta Kappa graduate of Harvard College (in Economics), and earned his MD from New York University School of Medicine. He completed his medical internship and residency at The New York-Presbyterian Hospital/Weill Cornell Medical Center, where he also completed his cardiology and cardiac electrophysiology training.
Prior to joining Boston Scientific in 2009, Dr. Stein held the position of Associate Director of Clinical Cardiac Electrophysiology at Weill Cornell Medical Center and Associate Professor of Medicine at Cornell University where he was widely published, authoring over 125 peer-reviewed scientific publications in the areas of cardiac electrophysiology with special interest in cardiac resynchronization therapy and risk stratification for sudden cardiac arrest. Dr. Stein currently oversees the clinical trials, medical safety, and medical education and clinical communications for Boston Scientific’s Cardiac Rhythm Management, Electrophysiology and Watchman Left Atrial Appendage Closure businesses as well as leading the corporate Global Health Policy team tasked with shaping the company’s policies with respect to global health care delivery and reimbursement.
Dr. Stein serves on the board of the Boston Scientific Political Action Committee and on the Scientific Advisory Board of Optum Labs. Since 2013, he has also served on the board of Childrens HeartLink, a registered 501c(3) nonprofit organization that trains and mentors medical teams in underserved parts of the world to diagnose and treat children with heart disease. Founded in 1969, Children’s HeartLink currently supports partner hospitals in Brazil, China, India, Malaysia, Ukraine and Vietnam.